Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A14051 | 29609450 | Ann Pediatr Endocrinol Metab | Hepatopulmonary syndrome caused by hypothalamic obesity and nonalcoholic fatty liver disease after surgery for craniopharyngioma: a case report. | 2018 | Details |
| A14052 | 29609136 | Cytokine | Fetuin-B links nonalcoholic fatty liver disease to type 2 diabetes via inducing insulin resistance: Association and path analyses. | 2018 | Details |
| A14053 | 29608898 | Eur J Pharmacol | Canagliflozin protects against non-alcoholic steatohepatitis in type-2 diabetic rats through zinc alpha-2 glycoprotein up-regulation. | 2018 | Details |
| A14054 | 29608451 | J Clin Gastroenterol | Nonalcoholic Fatty Liver is Contributing to the Increase in Cases of Liver Disease in US Emergency Departments. | 2019 | Details |
| A14055 | 29608442 | Eur J Gastroenterol Hepatol | Cognitive assessment of patients with nonalcoholic fatty liver disease. | 2018 | Details |
| A14056 | 29608255 | Liver Int | Twenty-five-year trajectories of insulin resistance and pancreatic β-cell response and diabetes risk in nonalcoholic fatty liver disease. | 2018 | Details |
| A14057 | 29607802 | Public Health Nutr | Intakes of magnesium, calcium and risk of fatty liver disease and prediabetes. | 2018 | Details |
| A14058 | 29607635 | J Korean Med Sci | Estimated Prevalence of Adolescents with Nonalcoholic Fatty Liver Disease in Korea. | 2018 | Details |
| A14060 | 29607054 | BMJ Open Gastroenterol | Non-alcoholic steatofibrosis (NASF) can independently predict mortality in patients with non-alcoholic fatty liver disease (NAFLD). | 2018 | Details |
| A14062 | 29604480 | Atherosclerosis | Nonalcoholic fatty liver disease and advanced fibrosis are associated with left ventricular diastolic dysfunction. | 2018 | Details |
| A14063 | 29604329 | Mol Cell Endocrinol | MiR-451a attenuates free fatty acids-mediated hepatocyte steatosis by targeting the thyroid hormone responsive spot 14 gene. | 2018 | Details |
| A14064 | 29604292 | Gastroenterology | Improved Diet Quality Associates With Reduction in Liver Fat, Particularly in Individuals With High Genetic Risk Scores for Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A14068 | 29603380 | Mol Carcinog | Identification of chromatin-accessible domains in non-alcoholic steatohepatitis-derived hepatocellular carcinoma. | 2018 | Details |
| A14069 | 29603365 | J Gastroenterol Hepatol | Can the same controlled attenuation parameter cut-offs be used for M and XL probes for diagnosing hepatic steatosis? | 2018 | Details |
| A14070 | 29603349 | J Leukoc Biol | Leukocyte extracellular vesicle concentration is inversely associated with liver fibrosis severity in NAFLD. | 2018 | Details |
| A14071 | 29602794 | Diabetes Care | Specific Hepatic Sphingolipids Relate to Insulin Resistance, Oxidative Stress, and Inflammation in Nonalcoholic Steatohepatitis. | 2018 | Details |
| A14072 | 29602237 | J Cell Mol Med | NEFA-induced ROS impaired insulin signalling through the JNK and p38MAPK pathways in non-alcoholic steatohepatitis. | 2018 | Details |
| A14073 | 29601997 | Contemp Clin Trials | Effectiveness of a carbohydrate restricted diet to treat non-alcoholic fatty liver disease in adolescents with obesity: Trial design and methodology. | 2018 | Details |
| A14074 | 29601441 | J Pediatr Gastroenterol Nutr | The Membrane-bound O-Acyltransferase7 rs641738 Variant in Pediatric Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A14075 | 29601135 | Hepatol Res | Effects of knee loading on obesity-related non-alcoholic fatty liver disease in an ovariectomized mouse model with high-fat diet. | 2018 | Details |
| A14078 | 29600696 | Minerva Gastroenterol Dietol | Helicobacter pylori in metabolic related diseases. | 2018 | Details |
| A14079 | 29600657 | Zhongguo Zhong Yao Za Zhi | [Effect of leech on lipid metabolism and liver in hyperlipidemia rats]. | 2018 | Details |
| A14080 | 29600430 | Hepatol Int | Targeting incretin hormones and the ASK-1 pathway as therapeutic options in the treatment of non-alcoholic steatohepatitis. | 2018 | Details |
| A14081 | 29599925 | Oncotarget | A porcine placental extract prevents steatohepatitis by suppressing activation of macrophages and stellate cells in mice. | 2018 | Details |
| A14082 | 29599631 | Malays J Med Sci | The Effect of Amygdalin on Endoplasmic Reticulum (ER) Stress Induced Hepatic Steatosis in Mice. | 2018 | Details |
| A14085 | 29595690 | Medicine (Baltimore) | A novel index including SNPs for the screening of nonalcoholic fatty liver disease among elder Chinese: A population-based study. | 2018 | Details |
| A14086 | 29595666 | Medicine (Baltimore) | Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD). | 2018 | Details |
| A14087 | 29594475 | Eur J Nutr | Individual fatty acids in erythrocyte membranes are associated with several features of the metabolic syndrome in obese children. | 2018 | Details |
| A14088 | 29594435 | Eur J Nutr | Higher serum carotenoids associated with improvement of non-alcoholic fatty liver disease in adults: a prospective study. | 2018 | Details |
| A14089 | 29594192 | Clin Exp Hepatol | The influence of NAFLD on the risk of atherosclerosis and cardiovascular diseases. | 2018 | Details |
| A14090 | 29593815 | Arch Med Sci | Preventive effects of total saponins of Panax japonicus on fatty liver fibrosis in mice. | 2016 | Details |
| A14091 | 29593573 | Front Physiol | Rho, a Fraction From Rhodiola crenulate, Ameliorates Hepatic Steatosis in Mice Models. | 2018 | Details |
| A14092 | 29592806 | J Biomed Sci | β-aminoisobutyric acid attenuates LPS-induced inflammation and insulin resistance in adipocytes through AMPK-mediated pathway. | 2018 | Details |
| A14093 | 29590715 | Acta Clin Croat | Nutritional Status and Nutrition Quality in Patients with Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A14094 | 31089541 | J Obes Metab Syndr | Nonalcoholic Fatty Liver Disease and Abdominal Fat Accumulation According to Vitamin D Status in Patients with Type 2 Diabetes. | 2018 | Details |
| A14095 | 29590379 | J Clin Endocrinol Metab | Increased Plasma Proneurotensin Levels Identify NAFLD in Adults With and Without Type 2 Diabetes. | 2018 | Details |
| A14096 | 29590099 | PLoS Med | Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database. | 2018 | Details |
| A14097 | 29589386 | Endocrinol Metab (Seoul) | Association of Adipokines with Development and Progression of Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A14098 | 29588839 | Frontline Gastroenterol | Non-invasive markers of liver fibrosis in fatty liver disease are unreliable in people of South Asian descent. | 2017 | Details |
| A14099 | 29588137 | Diabetes Metab Syndr | Vitamin D supplementation for the treatment of non-alcoholic fatty liver disease: A randomized double blind placebo controlled trial. | 2018 | Details |
| A14100 | 29587769 | Reprod Biol Endocrinol | Circulating osteopontin and its association with liver fat content in non-obese women with polycystic ovary syndrome: a case control study. | 2018 | Details |
| A14101 | 29584615 | J Pediatr Endocrinol Metab | Metabolic and genetic markers' associations with elevated levels of alanine aminotransferase in adolescents. | 2018 | Details |
| A14102 | 29584449 | Crit Rev Food Sci Nutr | Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials: Synbiotic supplementation and NAFLD. | 2018 | Details |
| A14103 | 29583004 | J Agric Food Chem | Effects of Stigmasterol and β-Sitosterol on Nonalcoholic Fatty Liver Disease in a Mouse Model: A Lipidomic Analysis. | 2018 | Details |
| A14104 | 29581157 | J Lipid Res | Regulation of mitochondrial trifunctional protein modulates nonalcoholic fatty liver disease in mice. | 2018 | Details |
| A14105 | 29580823 | Mol Cell Endocrinol | GW0742 (PPAR-beta agonist) attenuates hepatic endoplasmic reticulum stress by improving hepatic energy metabolism in high-fat diet fed mice. | 2018 | Details |
| A14106 | 29580767 | Eur J Intern Med | Fatty liver index is associated to pulse wave velocity in healthy subjects: Data from the Brisighella Heart Study. | 2018 | Details |
| A14107 | 29579601 | Int J Cardiol | Circulating Interleukin-6 is a biomarker for coronary atherosclerosis in nonalcoholic fatty liver disease: Results from the Multi-Ethnic Study of Atherosclerosis. | 2018 | Details |
| A14108 | 29578593 | Cancer | High frequency of the PNPLA3 rs738409 [G] single-nucleotide polymorphism in Hmong individuals as a potential basis for a predisposition to chronic liver disease. | 2018 | Details |
| A14109 | 29577863 | Curr Clin Pharmacol | Hepatic Elimination of Drugs in Gestational Diabetes. | 2018 | Details |
| A14110 | 29577833 | Am J Mens Health | Association Between Nonalcoholic Fatty Liver Disease and Severe Male Reproductive Organ Impairment (Germinal Epithelial Loss): Study on a Mouse Model and on Human Patients. | 2018 | Details |
| A14111 | 29577560 | Liver Int | Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population. | 2018 | Details |
| A14112 | 29577364 | Aliment Pharmacol Ther | Screening for therapeutic trials and treatment indication in clinical practice: MACK-3, a new blood test for the diagnosis of fibrotic NASH. | 2018 | Details |
| A14114 | 29575516 | Liver Int | Diabetes impacts prediction of cirrhosis and prognosis by non-invasive fibrosis models in non-alcoholic fatty liver disease. | 2018 | Details |
| A14115 | 29575149 | J Cell Biochem | Exercise decreases CLK2 in the liver of obese mice and prevents hepatic fat accumulation. | 2018 | Details |
| A14116 | 29575055 | J Cell Biochem | MicroRNA-190b regulates lipid metabolism and insulin sensitivity by targeting IGF-1 and ADAMTS9 in non-alcoholic fatty liver disease. | 2018 | Details |
| A14117 | 29575023 | Clin Transplant | Progression and new onset of nonalcoholic fatty liver disease in living kidney donors compared to healthy controls. | 2018 | Details |
| A14118 | 29574933 | Clin Exp Pharmacol Physiol | The association of serum FGF23 and non-alcoholic fatty liver disease is independent of vitamin D in type 2 diabetes patients. | 2018 | Details |
| A14121 | 29574608 | Eur J Nutr | Fish intake interacts with TM6SF2 gene variant to affect NAFLD risk: results of a case-control study. | 2018 | Details |
| A14122 | 29574534 | J Gastroenterol | To die or not to die: death signaling in nonalcoholic fatty liver disease. | 2018 | Details |
| A14123 | 29574225 | Pharmacol Res | Dioscin alleviates non-alcoholic fatty liver disease through adjusting lipid metabolism via SIRT1/AMPK signaling pathway. | 2018 | Details |
| A14124 | 29573006 | Hepatology | Ubiquitin-Specific Protease 4 Is an Endogenous Negative Regulator of Metabolic Dysfunctions in Nonalcoholic Fatty Liver Disease in Mice. | 2018 | Details |
| A14125 | 29572891 | Hepatology | Link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD. | 2018 | Details |
| A14126 | 29572825 | J Surg Oncol | New onset non-alcoholic fatty liver disease after resection of pancreatic neuroendocrine tumors. | 2018 | Details |
| A14127 | 29572551 | Sci Rep | Lack of evidence supporting a role of TMC4-rs641738 missense variant-MBOAT7- intergenic downstream variant-in the Susceptibility to Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A14128 | 29572342 | J Pharmacol Exp Ther | Protectin DX Ameliorates Hepatic Steatosis by Suppression of Endoplasmic Reticulum Stress via AMPK-Induced ORP150 Expression. | 2018 | Details |
| A14129 | 29572095 | J Hepatol | A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer. | 2018 | Details |
| A14130 | 29571977 | Diabetes Metab Syndr | Non-alcoholic fatty liver disease and associated dietary and lifestyle risk factors. | 2018 | Details |
| A14131 | 29571924 | J Hepatol | High red and processed meat consumption is associated with non-alcoholic fatty liver disease and insulin resistance. | 2018 | Details |
| A14132 | 29570976 | Anal Chem | Spatial Systems Lipidomics Reveals Nonalcoholic Fatty Liver Disease Heterogeneity. | 2018 | Details |
| A14133 | 29570139 | J Pediatr Gastroenterol Nutr | Prevalence of Suspected Nonalcoholic Fatty Liver Disease in Lean Adolescents in the United States. | 2018 | Details |
| A14134 | 29569850 | CPT Pharmacometrics Syst Pharmacol | Modeling of the Weight Status and Risk of Nonalcoholic Fatty Liver Disease in Elderly Individuals: The Potential Impact of the Disulfide Bond-Forming Oxidoreductase A-Like Protein (DsbA-L) Polymorphism on the Weight Status. | 2018 | Details |
| A14135 | 29569260 | Clin Exp Pharmacol Physiol | Down-regulation of microRNA-375 regulates adipokines and inhibits inflammatory cytokines by targeting AdipoR2 in non-alcoholic fatty liver disease. | 2018 | Details |
| A14136 | 29568887 | Int J Mol Med | Genome-wide analysis of DNA methylation in human peripheral leukocytes identifies potential biomarkers of nonalcoholic fatty liver disease. | 2018 | Details |
| A14137 | 29568204 | World J Gastroenterol | Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease. | 2018 | Details |
| A14138 | 29568101 | Int J Obes (Lond) | CYP2A6 is associated with obesity: studies in human samples and a high fat diet mouse model. | 2018 | Details |
| A14139 | 29567280 | Bull Cancer | [Hepatocellular carcinoma: Increase in incidence or future plague?] | 2018 | Details |
| A14140 | 29567249 | J Food Drug Anal | Mulberry Leaf Extracts prevent obesity-induced NAFLD with regulating adipocytokines, inflammation and oxidative stress. | 2017 | Details |
| A14141 | 29566909 | Best Pract Res Clin Gastroenterol | NAFLD, Helicobacter species and the intestinal microbiome. | 2017 | Details |
| A14142 | 29565984 | PLoS One | Severity of nonalcoholic fatty liver disease is associated with subclinical cerebro-cardiovascular atherosclerosis risk in Korean men. | 2018 | Details |
| A14143 | 29565507 | Eur Rev Med Pharmacol Sci | Analysis of the correlation between non-alcoholic fatty liver disease and bone metabolism indicators in healthy middle-aged men. | 2018 | Details |
| A14144 | 29565153 | Nutr Hosp | Inflammatory cytokines and non-alcoholic fatty liver disease (NAFLD) in obese children and adolescents. | 2018 | Details |
| A14145 | 29564257 | J Family Med Prim Care | Relationship between serum ferritin level and transient elastography findings among patients with nonalcoholic fatty liver disease. | 2022 | Details |
| A14146 | 29564062 | Gastroenterol Hepatol Bed Bench | Protein-protein interaction analysis of Alzheimer`s disease and NAFLD based on systems biology methods unhide common ancestor pathways. | 2018 | Details |
| A14147 | 29564059 | Gastroenterol Hepatol Bed Bench | Is treatment of fatty liver effective on reducing carotid intima media thickness; a cohort study. | 2018 | Details |
| A14148 | 29563875 | Front Pharmacol | Mangiferin Improves Hepatic Lipid Metabolism Mainly Through Its Metabolite-Norathyriol by Modulating SIRT-1/AMPK/SREBP-1c Signaling. | 2018 | Details |
| A14149 | 29563854 | Mediators Inflamm | Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A14150 | 29563328 | JCI Insight | Peroxisomal β-oxidation regulates whole body metabolism, inflammatory vigor, and pathogenesis of nonalcoholic fatty liver disease. | 2018 | Details |
| A14151 | 29562725 | Int J Mol Sci | Genetic and Epigenetic Regulation in Nonalcoholic Fatty Liver Disease (NAFLD). | 2018 | Details |
| A14152 | 29562379 | Acta Gastroenterol Belg | The Belgian Association for Study of the Liver Guidance Document on the Management of Adult and Paediatric Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
| A14153 | 29561981 | Arq Gastroenterol | MEASUREMENT OF CONTROLLED ATTENUATION PARAMETER: A SURROGATE MARKER OF HEPATIC STEATOSIS IN PATIENTS OF NONALCOHOLIC FATTY LIVER DISEASE ON LIFESTYLE MODIFICATION - A PROSPECTIVE FOLLOW-UP STUDY. | 2018 | Details |
| A14154 | 29561732 | Rom J Intern Med | The severity of coronary artery disease was not associated with non-alcoholic fatty liver disease in a series of 264 non-diabetic patients who underwent coronary angiography. | 2018 | Details |
| A14155 | 29560749 | Artif Cells Nanomed Biotechnol | Targeted delivery of microRNA 146b mimic to hepatocytes by lactosylated PDMAEMA nanoparticles for the treatment of NAFLD. | 2018 | Details |
| A14156 | 29560693 | Acta Gastroenterol Belg | Apoptosis and Disease Severity is Associated with Insulin Resistance in Non-alcoholic Fatty Liver Disease. | 2018 | Details |
| A14157 | 29560688 | Acta Gastroenterol Belg | Prevalence of fat-soluble vitamin (A, D, and E) and zinc deficiency in patients with cirrhosis being assessed for liver transplantation. | 2018 | Details |
| A14158 | 29560647 | Acta Gastroenterol Belg | Hepatic complications of bariatric surgery : the reverse side of the coin. | 2018 | Details |
| A14159 | 29558460 | Int J Mol Sci | p53 as a Dichotomous Regulator of Liver Disease: The Dose Makes the Medicine. | 2018 | Details |
| A14160 | 29558390 | Int J Mol Sci | PPARβ/δ: A Key Therapeutic Target in Metabolic Disorders. | 2018 | Details |
| A14161 | 29557675 | Crit Rev Biochem Mol Biol | The hedgehog pathway in nonalcoholic fatty liver disease. | 2018 | Details |
| A14162 | 29557414 | J Gastrointestin Liver Dis | A Multi-strain Probiotic Reduces the Fatty Liver Index, Cytokines and Aminotransferase levels in NAFLD Patients: Evidence from a Randomized Clinical Trial. | 2018 | Details |